Multiple Sclerosis Clinical Trial

Improving Learning in Hispanics With TBI or MS

Summary

The goal of this study is to establish that a memory retraining protocol, originally developed for English-speakers, and translated into Spanish, is effective.

View Full Description

Full Description

A pilot study will be conducted to carry out this validation and resolve any methodological concerns in the translated protocol. 20 Spanish-speaking Hispanics at least one year post-traumatic brain injury (TBI) and 20 Spanish-speaking Hispanics with multiple sclerosis (MS), both with an objective deficit in learning and memory will be recruited. Baseline assessment includes neuropsychological evaluation using traditional measures as well as completion of a number of questionnaires designed to measure everyday memory and everyday functioning. Subjects are randomly assigned to either the experimental or control groups. Experimental and control treatments includes two 45-60 minute sessions, twice per week, for 5 weeks. Follow-up assessment includes a neuropsychological evaluation using traditional measures as well as completion of a number of questionnaires designed to measure everyday memory and everyday functioning. Protocol efficacy will be determined by improvements between baseline and follow-up on an objective measure of learning and memory.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

between the ages of 18 and 65
Spanish is my dominant language, and I have had a traumatic brain injury or I have multiple sclerosis.

Exclusion Criteria:

Participants with major depressive disorder, schizophrenia, bipolar disorder I or II
MS subjects: Individuals with a history of head injury, stroke, seizures, or any other significant neurological history will not be included in the study.
TBI subjects: Individuals must have sustained a TBI at least one year prior to enrollment in the study protocol. Individuals with a history of significant neurological insult other than TBI (e.g. premorbid epilepsy, multiple sclerosis, Alzheimer's disease) will not be included in the study.

Study is for people with:

Multiple Sclerosis

Estimated Enrollment:

40

Study ID:

NCT03453125

Recruitment Status:

Recruiting

Sponsor:

Kessler Foundation

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Kessler Foundation
East Hanover New Jersey, 07936, United States More Info
Denise Krch, PhD
Contact
973-324-8392
[email protected]
Belinda Washington, BA
Contact
973-324-8440
[email protected]
Hospital Aita Menni
Arrasate-Mondragón , , Spain More Info
Garazi Labayr Isusquiza, PhD
Contact
+34 943794411
[email protected]
Jose Ignacio, MD
Contact
+34 943794411
[email protected]

How clear is this clinincal trial information?

Study is for people with:

Multiple Sclerosis

Estimated Enrollment:

40

Study ID:

NCT03453125

Recruitment Status:

Recruiting

Sponsor:


Kessler Foundation

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider